- Home
- CMCL vs BME Comparison
CMCL vs BME Comparison
Compare CMCL & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CMCL | BME |
|---|---|---|
| Founded | 1992 | N/A |
| Country | Jersey | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Trusts Except Educational Religious and Charitable |
| Sector | Basic Materials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 552.3M | 547.5M |
| IPO Year | 2003 | 2005 |
Fundamental Metrics
Financial Performance| Metric | CMCL | BME |
|---|---|---|
| Price | $26.13 | $40.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $28.00 | N/A |
| AVG Volume (30 Days) | ★ 259.3K | 36.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.16% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $57.27 | N/A |
| Revenue Next Year | $28.69 | N/A |
| P/E Ratio | $10.88 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.60 | $34.18 |
| 52 Week High | $38.75 | $42.74 |
Technical Indicators
Market Signals| Indicator | CMCL | BME |
|---|---|---|
| Relative Strength Index (RSI) | 39.38 | 33.65 |
| Support Level | $25.99 | $40.55 |
| Resistance Level | $28.99 | $42.55 |
| Average True Range (ATR) | 1.59 | 0.59 |
| MACD | -0.58 | -0.19 |
| Stochastic Oscillator | 12.99 | 17.27 |
Price Performance
Historical ComparisonAbout CMCL Caledonia Mining Corporation Plc
Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the Blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. The company's project includes Maligreen and Motapa.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.